Claims for Patent: 3,624,205
✉ Email this page to a colleague
Summary for Patent: 3,624,205
Title: | TREATMENT OF HYPERURICEMIA IN HUMANS |
Abstract: | The method of treatment and prophylaxis for hyperuricemia, which comprises administering to a human patient a therapeutically effective amount of a compound selected from the class consisting of 4-hydroxy-1-H-pyrazolo(3,4-d)pyrimidine and 4,6-dihydroxy-1-H-pyrazolo(3,4-d)pyrimidine. |
Inventor(s): | Hitchings; George H. (Yonkers, NY), Falco; Elvira A. (New Rochelle, NY) |
Assignee: | Burroughs Wellcome & Co. (U.S.A.) Inc. (Tuckahoe, NY) |
Application Number: | 04/633,364 |
Patent Claims: |
1. The method of treatment and prophylaxis for hyperuricemia, which comprises administering to a human patient a therapeutically effective amount of a compound
4-hydroxy-1-H-pyrazolo(3,4-d)pyrimidine.
2. The method of claim 1, wherein the compound 4-hydroxy-1-H-pyrazolo(3,4-d)pyrimidine is administered at a dosage of 2 to 30 mg./kg. of the body weight of the human patient treated. 3. The method of treatment and prophylaxis for hyperuricemia, which comprises administering to a human patient a therapeutically effective amount of a compound 4,6-dihydroxy-1-H-pyrazolo(3,4-d)pyrimidine. 4. The method claim 3, wherein the compound 4,6-dihydroxy-1-H-pyrazolo(3,4-d)pyrimidine is administered at a dosage of 2 to 30 mg./kg. of the body weight of the human patient treated. 5. The method of treatment and prophylaxis for hyperuricemia, which comprises administering to a human patient a therapeutically effective amount of a compound selected from the class consisting of 4-hydroxy-1-H-pyrazolo(3,4-d)pyrimidine and 4,6-dihydroxy-1-H-pyrazolo-(3,4-d)pyrimidine. |